Loading...
Loading...
Advanced Protocols
Detailed dosing schedules, cycling frameworks, stacking strategies, administration routes, sourcing best practices, and safety monitoring for 7 key peptides. This is the practical companion to our Peptides Overview Guide.
This guide is for educational purposes only and does not constitute medical advice. Peptides are potent bioactive compounds that require physician supervision for safe use. Most peptides discussed here are not FDA-approved for human use and exist in evolving regulatory territory.
Do not self-prescribe, self-inject, or use peptides without guidance from a licensed healthcare provider experienced in peptide therapy. Improper use can lead to adverse effects, drug interactions, and health risks. CryoCove does not sell, distribute, or prescribe peptides.
If you are currently using peptides without medical supervision, we strongly encourage you to establish care with a physician who can monitor your bloodwork, adjust protocols, and ensure your safety.
Foundations
Peptides are short chains of amino acids — typically between 2 and 50 amino acids linked by peptide bonds. They are essentially small proteins that function as signaling molecules, instructing your body's cells and systems on what to do. Your body naturally produces thousands of peptides that regulate everything from tissue repair to immune surveillance to hormone release.
Why peptides are different from hormones: Hormones are larger signaling molecules that circulate systemically and produce broad, whole-body effects. Peptides are smaller, more targeted, and typically work through specific receptor pathways. When you use a growth hormone secretagogue peptide (like CJC-1295/Ipamorelin), you are telling your pituitary gland to release more of its own growth hormone — you are not injecting exogenous growth hormone itself. This preserves your body's natural feedback loops.
Why peptides are different from steroids: Anabolic steroids are synthetic versions of hormones (primarily testosterone) that directly replace or supplement your endocrine system, often suppressing natural production. Peptides work with your body's feedback mechanisms rather than overriding them. This generally results in milder effects, fewer side effects, and easier recovery when discontinued.
The peptide landscape in 2026: Peptide therapy exists at the intersection of cutting-edge research and regulatory uncertainty. Some peptides have decades of published data (GHK-Cu, thymosin beta-4). Others have strong animal evidence but limited human clinical trials (BPC-157). One peptide in this guide (PT-141 / Vyleesi) is FDA-approved. The regulatory environment is shifting rapidly — the FDA has been increasing enforcement around compounding pharmacies while the research community continues to publish promising data.
The CryoCove position: We believe peptides are legitimate, powerful tools — and also that they are wildly overhyped in some biohacking circles. No peptide replaces sleep, nutrition, movement, and stress management. Our foundational 9 pillars should be optimized before considering peptides. When the foundation is solid, select peptides can provide meaningful incremental benefit for specific goals. This guide gives you the knowledge to have informed conversations with your physician.
Deep Dive
Each peptide with its mechanism, dosing, cycling, administration, evidence, side effects, contraindications, and stacking partners. All dosing information is for educational reference — your physician will determine the appropriate protocol for your situation.
Body Protection Compound-157
A 15-amino-acid peptide derived from human gastric juice. BPC-157 promotes angiogenesis (new blood vessel formation), upregulates growth hormone receptors in injured tissue, stimulates nitric oxide synthesis, and activates the FAK-paxillin pathway critical for tendon and ligament repair. It also modulates the dopaminergic and serotonergic systems, which may explain its observed effects on gut-brain axis function.
Typical Dose
250-500 mcg, 1-2x daily
Route
Subcutaneous injection near injury site, or oral for gut-specific effects
Cycle Length
4-8 weeks on, 2-4 weeks off
Half-Life
Estimated 4-6 hours (limited human pharmacokinetic data)
Timing
Morning and/or evening. For gut healing, oral dosing on empty stomach. For tissue repair, subcutaneous injection near the injured area.
Thymosin Beta-4 Fragment
TB-500 is a synthetic version of the active region of thymosin beta-4 (TB4), a 43-amino-acid protein naturally produced by the thymus gland. It upregulates actin, a cell-building protein essential for cell migration and tissue repair. TB-500 promotes blood vessel growth, reduces inflammation by downregulating inflammatory cytokines, and decreases fibrosis (scar tissue formation). It uniquely travels systemically — meaning it can reach injury sites throughout the body rather than only acting locally.
Typical Dose
2-2.5 mg, 2x per week (loading), then 2 mg 1x per week (maintenance)
Route
Subcutaneous injection (systemic distribution — injection site is less critical than BPC-157)
Cycle Length
4-6 weeks loading, 2-4 weeks maintenance, then 4 weeks off
Half-Life
Approximately 4-6 hours, but tissue effects persist longer due to actin upregulation
Timing
No strong timing preference. Many practitioners dose in the evening.
Copper Peptide (Glycyl-L-Histidyl-L-Lysine Copper Complex)
GHK-Cu is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. Plasma levels decline from ~200 ng/mL at age 20 to ~80 ng/mL by age 60. It activates wound healing pathways, stimulates collagen I and III synthesis, promotes glycosaminoglycan production (hyaluronic acid, dermatan sulfate), recruits immune cells to damaged tissue, and acts as a potent antioxidant by upregulating superoxide dismutase (SOD). GHK-Cu also remodels scar tissue into normal tissue architecture and has demonstrated gene-resetting properties — activating 31 human genes related to tissue repair and suppressing 36 genes related to inflammation and tissue destruction.
Typical Dose
Topical: 1-2% concentration serums. Subcutaneous: 200-500 mcg daily or every other day.
Route
Topical (most studied, widely available) or subcutaneous injection (for systemic effects)
Cycle Length
Topical: continuous use. Injection: 4-8 weeks on, 2-4 weeks off
Half-Life
Short — copper peptide is rapidly absorbed and metabolized, but downstream effects on gene expression persist
Timing
Topical: apply to clean skin morning and/or evening. Injection: typically morning.
Growth Hormone Secretagogue Stack
CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) with a Drug Affinity Complex (DAC) that extends its half-life. It amplifies the natural GH-release pulses from the pituitary gland. Ipamorelin is a selective ghrelin receptor agonist (growth hormone secretagogue) that stimulates GH release without significantly affecting cortisol, prolactin, or other hormones — making it one of the cleanest GH secretagogues available. Combined, they produce synergistic pulsatile GH release that mimics natural physiology: CJC-1295 raises the baseline, while Ipamorelin adds sharp pulses.
Typical Dose
CJC-1295: 100-300 mcg; Ipamorelin: 200-300 mcg. Combined 1-3x daily.
Route
Subcutaneous injection (typically abdominal or thigh)
Cycle Length
12-16 weeks on, 4-8 weeks off. Some practitioners run 5 days on / 2 days off.
Half-Life
CJC-1295 with DAC: ~6-8 days. Without DAC (mod GRF 1-29): ~30 minutes. Ipamorelin: ~2 hours.
Timing
Before bed (amplifies nocturnal GH pulse) and/or first thing in the morning on empty stomach. Avoid dosing within 1 hour of food — insulin blunts GH release.
Bremelanotide
PT-141 (bremelanotide) is a cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH). Unlike PDE5 inhibitors (Viagra, Cialis) that act on vascular smooth muscle, PT-141 acts centrally in the brain through melanocortin-4 receptors (MC4R) in the hypothalamus. This means it affects sexual desire and arousal at the neurological level, not just the mechanical level. It increases dopaminergic signaling in the mesolimbic pathway — the brain's reward and motivation circuit. PT-141 is notable as the only FDA-approved peptide for hypoactive sexual desire disorder (HSDD) in premenopausal women (marketed as Vyleesi).
Typical Dose
1.75 mg (FDA-approved dose for HSDD). Anecdotal ranges: 0.5-2 mg.
Route
Subcutaneous injection (typically abdomen or thigh). Previously studied as nasal spray.
Cycle Length
As-needed dosing, not daily. Max: once in 24 hours, no more than 8 doses per month.
Half-Life
Approximately 2.7 hours. Peak plasma: ~1 hour after injection. Effects last 6-72 hours.
Timing
45-60 minutes before anticipated activity. Effects can persist for 12-72 hours in some individuals.
Lys-Pro-Val (Alpha-MSH Fragment)
KPV is a tripeptide fragment (Lysine-Proline-Valine) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). Despite being only 3 amino acids, KPV retains the potent anti-inflammatory properties of the full alpha-MSH molecule. It enters cells and directly inhibits NF-kB and MAPK inflammatory signaling pathways — two of the master switches of inflammation. KPV is uniquely suited for gut inflammation because it can be administered orally and act locally on intestinal epithelial cells, reducing inflammatory cytokine production (IL-1beta, IL-6, TNF-alpha) in the gut lining without requiring systemic absorption.
Typical Dose
200-500 mcg orally, 1-2x daily for gut. 200-400 mcg subcutaneous for systemic.
Route
Oral capsule (for gut-specific effects) or subcutaneous injection (for systemic anti-inflammatory). Topical for skin.
Cycle Length
4-12 weeks for gut protocols. Can be used longer under medical supervision.
Half-Life
Short — rapidly metabolized. Oral dosing provides local gut effects rather than sustained systemic levels.
Timing
Oral: on empty stomach (30 min before food) for maximal gut contact. Subcutaneous: morning or evening.
Epitalon / Epithalamin (Ala-Glu-Asp-Gly)
Epithalon is a synthetic tetrapeptide based on epithalamin, a hormone naturally produced by the pineal gland. Its primary mechanism is activation of telomerase — the enzyme that lengthens telomeres, the protective caps on chromosome ends that shorten with each cell division. Telomere shortening is one of the nine hallmarks of aging. Beyond telomerase activation, Epithalon modulates melatonin production (restoring youthful circadian rhythms), acts as an antioxidant, and has demonstrated effects on gene expression related to cell senescence and immune function. The research base comes primarily from Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, who has published over 200 papers on bioregulatory peptides.
Typical Dose
5-10 mg daily for 10-20 consecutive days
Route
Subcutaneous injection or intravenous (clinical settings)
Cycle Length
10-20 day cycles, repeated 2-3x per year. Not continuous use.
Half-Life
Very short — minutes. However, downstream effects on telomerase gene expression persist for weeks to months.
Timing
Morning or evening. Some practitioners align with circadian rhythm (evening dosing for melatonin effects).
Want This Personalized?
This guide gives you the science. A CryoCove coach gives you the personalization — the right dose, timing, and integration with your other 8 pillars.
How to Administer
Each route offers different bioavailability, onset of action, and suitability for specific peptides. Your physician will determine the best route for your protocol.
The most common route for peptide administration. A small needle (27-31 gauge, insulin syringe) is used to inject into the fatty tissue just beneath the skin — typically the abdomen, thigh, or upper arm. Subcutaneous delivery provides predictable absorption and good bioavailability for most peptides.
Best for: BPC-157 (near injury), TB-500, CJC-1295/Ipamorelin, PT-141, KPV (systemic), Epithalon, GHK-Cu (systemic)
Practical Tips
Some peptides can be taken orally, though most are degraded by stomach acid and digestive enzymes. BPC-157 is a notable exception — its gastric origin means it is stable in the GI tract. KPV can also be taken orally for localized gut effects. Oral peptides generally have lower systemic bioavailability but can be highly effective for gut-specific targets.
Best for: BPC-157 (gut healing specifically), KPV (gut inflammation)
Practical Tips
Applied directly to the skin as creams, serums, or gels. Most effective for peptides with localized skin and hair benefits. GHK-Cu is the most well-studied topical peptide, with decades of human data showing improvements in collagen production, wound healing, and hair growth.
Best for: GHK-Cu (skin, hair, wounds), KPV (dermatitis, skin inflammation)
Practical Tips
Delivery through the nasal mucosa, which provides rapid absorption into systemic circulation and can bypass the blood-brain barrier for neurologically-targeted peptides. Less common for the peptides covered in this guide, but relevant for related peptides like Selank and BPC-157 nasal formulations being explored for cognitive effects.
Best for: Selank (anxiolytic), some BPC-157 formulations (experimental for cognitive effects)
Practical Tips
Synergistic Combinations
Certain peptides work synergistically when combined. These are the 4 most evidence-supported stacking protocols. Always introduce peptides one at a time so you can isolate effects and side effects before combining.
Goal: Accelerated healing of tendons, ligaments, muscles, and connective tissue
Peptides
BPC-157 + TB-500
Protocol
BPC-157: 250-500 mcg subcutaneous near injury site, 2x daily. TB-500: 2-2.5 mg subcutaneous 2x per week for 4 weeks (loading), then 2 mg 1x per week (maintenance).
Rationale
BPC-157 acts locally to promote angiogenesis and growth factor upregulation at the injury site, while TB-500 works systemically through actin upregulation and cell migration. Together, they address both local and systemic repair pathways. This is the most widely used peptide stack in sports medicine and recovery.
Duration: 6-8 weeks
Goal: Repair intestinal barrier, reduce gut inflammation, restore gut lining integrity
Peptides
BPC-157 (oral) + KPV (oral)
Protocol
BPC-157: 250-500 mcg oral capsule, 2x daily on empty stomach. KPV: 200-500 mcg oral capsule, 1-2x daily on empty stomach.
Rationale
BPC-157 heals the gut mucosa directly — it is derived from gastric juice and is stable in the GI tract. KPV inhibits NF-kB in intestinal epithelial cells, shutting down the inflammatory cascade that perpetuates gut barrier damage. Combined, they address both the structural repair and the inflammatory driver.
Duration: 8-12 weeks
Goal: Comprehensive cellular anti-aging — telomere maintenance, GH optimization, skin repair
Peptides
Epithalon + CJC-1295/Ipamorelin + GHK-Cu
Protocol
Epithalon: 5-10 mg daily for 10-20 days, 2-3x per year. CJC-1295/Ipamorelin: 100-300 mcg / 200-300 mcg combined before bed, 5 days on / 2 off for 12 weeks. GHK-Cu: topical 1-2% daily (continuous) or subcutaneous 200-500 mcg every other day for 4-8 weeks.
Rationale
Epithalon addresses telomere shortening (one of the 9 hallmarks of aging). CJC-1295/Ipamorelin restores youthful growth hormone levels (GH declines ~14% per decade after age 30). GHK-Cu resets gene expression toward youthful repair patterns and stimulates collagen. Together, they target aging at three different levels: chromosomal, hormonal, and tissue-level.
Duration: Epithalon: 10-20 day cycles. CJC-1295/Ipamorelin: 12-16 weeks. GHK-Cu: ongoing or cycling.
Goal: Faster recovery from training, improved body composition, enhanced sleep quality
Peptides
CJC-1295/Ipamorelin + BPC-157
Protocol
CJC-1295/Ipamorelin: 100-300 mcg / 200-300 mcg combined, before bed nightly (5 days on, 2 off). BPC-157: 250-500 mcg subcutaneous, 1-2x daily (target areas of chronic soreness or injury).
Rationale
CJC-1295/Ipamorelin amplifies the nocturnal growth hormone pulse, enhancing deep sleep, fat metabolism, and muscle recovery. BPC-157 accelerates tissue repair and reduces inflammation at specific injury sites. The GH elevation from CJC/Ipamorelin synergizes with BPC-157's local healing effects.
Duration: 12-16 weeks for CJC/Ipamorelin; 4-8 weeks for BPC-157
Important: Never start multiple peptides simultaneously. Introduce one peptide at a time for at least 1-2 weeks before adding another. This allows you to identify which peptide is causing any side effects and adjust accordingly. Your physician should guide the timing of introductions based on your bloodwork and response.
On & Off
Peptides are not meant for indefinite continuous use. Strategic cycling preserves receptor sensitivity, allows assessment of benefits, and reduces risk.
Cycling prevents receptor desensitization (downregulation), allows you to assess your body's response during off periods, reduces the risk of unknown long-term effects, and gives your endocrine system periodic breaks. Some peptides (like growth hormone secretagogues) can cause the body to become less responsive over time if used continuously. Cycling preserves efficacy.
These are typically run for 4-8 weeks targeting a specific injury or condition, then discontinued once healing goals are met. If chronic issues persist, cycle 4-8 weeks on, 2-4 weeks off. The goal is resolution, not indefinite use.
Longer cycles are common: 12-16 weeks on, followed by 4-8 weeks off. Some practitioners use a 5-days-on / 2-days-off micro-cycle within the larger cycle. Off periods allow pituitary sensitivity to reset. Monitor IGF-1 levels during use to ensure you are not exceeding physiological ranges.
Epithalon uses short, intense cycles: 10-20 days on, then several months off. Telomerase activation persists well beyond the dosing period. Most protocols call for 2-3 cycles per year. This is not a peptide for continuous daily use.
PT-141 is dosed as needed, not on a cycle. Use no more than once in 24 hours and no more than 8 times per month. Regular daily use can cause melanocortin receptor desensitization and darkening of skin (hyperpigmentation).
Non-Negotiable
Any responsible peptide protocol requires baseline and ongoing blood work. These are the 7 key tests your physician should order. Do not skip this — it is the difference between informed optimization and reckless self-experimentation.
Assesses liver and kidney function — the primary organs that metabolize and clear peptides. Catches any hepatic or renal stress early.
Direct measure of growth hormone activity. IGF-1 should remain within the upper-normal physiological range (150-250 ng/dL depending on age). Supra-physiological IGF-1 increases cancer risk.
Growth hormone peptides can affect insulin sensitivity. Monitor for insulin resistance, especially with CJC-1295/Ipamorelin. If fasting insulin rises above 8-10 uIU/mL, reassess dosing.
Monitors red blood cells, white blood cells, and platelets. Some peptides modulate immune function (TB-500, Epithalon) — CBC ensures no abnormal shifts in immune cell populations.
Growth hormone influences thyroid hormone conversion (T4 to T3). GH peptides can unmask subclinical hypothyroidism or alter thyroid medication requirements.
Tracks systemic inflammation. Useful for monitoring anti-inflammatory peptides (BPC-157, KPV) and ensuring no inflammatory response to the peptides themselves.
Baseline screening before using any peptide that promotes cell proliferation or angiogenesis. If tumor markers are elevated at baseline, growth-promoting peptides are contraindicated.
Where to Get Peptides
The quality of your peptide source is arguably more important than the peptide itself. Contaminated, under-dosed, or incorrectly synthesized peptides can be ineffective or dangerous. Here is how the sourcing landscape breaks down.
The gold standard for peptide sourcing. 503A pharmacies fill individual prescriptions from licensed physicians. 503B pharmacies are outsourcing facilities that operate under stricter FDA oversight with batch testing requirements. Both require a valid prescription.
A growing number of telehealth platforms connect patients with physicians who prescribe peptides and dispense through affiliated compounding pharmacies. These vary enormously in quality — some are rigorous with comprehensive bloodwork requirements, while others are essentially peptide dispensaries with minimal medical oversight.
Companies that sell peptides labeled 'for research purposes only' and 'not for human consumption.' These operate in a legal gray area. Product quality is highly variable — some suppliers provide legitimate third-party testing, while others sell under-dosed, contaminated, or incorrectly synthesized products.
HPLC Purity
Target: > 98% purity
Confirms the peptide is the correct molecule with minimal impurities
Mass Spectrometry (MS)
Target: Correct molecular weight
Verifies the peptide has the correct amino acid sequence
Endotoxin Testing (LAL)
Target: < 5 EU/mg
Ensures no bacterial contamination that could cause fever or inflammation
Sterility Testing
Target: No growth
Confirms the product is free from bacteria, fungi, and other microorganisms
Regulatory Landscape
Peptide legality is complex, jurisdiction-dependent, and rapidly evolving. This overview reflects the general landscape as of early 2026 — always verify current regulations in your specific jurisdiction.
Most peptides in this guide are not FDA-approved for human use. The exception is PT-141 (bremelanotide), marketed as Vyleesi for HSDD. Physicians can prescribe non-approved peptides through compounding pharmacies for off-label use, but the FDA has been restricting which peptides can be compounded.
In 2023-2024, the FDA placed several popular peptides (including BPC-157 and certain GH secretagogues) on the Category 2 nominations list, which could restrict their compounding. The regulatory situation is fluid — check with a knowledgeable physician or attorney for current status.
“Research chemical” peptides sold online are technically legal to purchase but are labeled “not for human consumption.” Using them in humans exists in a legal gray area.
WADA prohibits all growth hormone secretagogues (CJC-1295, Ipamorelin, GHRP-2, GHRP-6, etc.), TB-500 (thymosin beta-4), and BPC-157 in competition and out-of-competition. GHK-Cu and KPV are not currently on the WADA prohibited list but this can change with annual updates. If you are subject to anti-doping testing, assume all performance-enhancing peptides are banned unless confirmed otherwise with your sport's anti-doping authority.
Regulations vary widely. In Australia, peptides were reclassified as Schedule 4 (prescription-only) in 2023. In the UK, peptides are generally legal to possess but illegal to sell for human consumption without a license. In Canada, peptides fall under the Food and Drugs Act and require a prescription. In Russia, several peptides (including Epithalon and Selank) have been studied extensively and some are approved for clinical use. Always check the specific laws in your country before obtaining peptides.
FAQ
This guide is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Peptides are potent bioactive compounds — most are not FDA-approved for human use. Always consult a licensed healthcare provider before starting any peptide protocol, especially if you take medications, have existing health conditions, or have a history of cancer. Individual responses vary significantly. CryoCove does not sell, distribute, or prescribe peptides. See our full disclaimer.
CryoCove coaching focuses on the foundational pillars that make advanced interventions like peptides actually effective — sleep, nutrition, movement, cold exposure, breathwork, and more. Get your basics dialed in first, then consider what comes next.